Why the study?
Although participants achieved reductions in abdominal and ectopic fat during two lifestyle trials, the long-term postintervention cardiometabolic profile associated with these changes remained to be examined.
Does lifestyle-induced visceral fat loss improve long-term cardiometabolic health and reduce incident type 2 diabetes in participants of dietary trials?
Population
366 participants from the CENTRAL and DIRECT-PLUS trials
Comparison
Dietary patterns combined with structured physical activity
Design
Post-trial follow-up of 2 randomized controlled trials
Follow-up
5 and 10 years after completion of the trials
Key result
Each 10% intervention-induced loss of visceral adipose tissue was associated with a 28% lower risk of incident type 2 diabetes (HR 0.72; 95% CI 0.54-0.94) during 5- and 10-year follow-up.
Authors
Loading...
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Repeated participation in a lifestyle program for weight loss, even after a perceived 'failure,' may lead to significant health benefits over the years, especially in reducing dangerous abdominal fat.”
“Weight alone does not accurately reflect abdominal fat or blood parameters. Therefore, even if the weight comes back, it is very possible that health is still improved, and the success of a process cannot be defined solely by a number on the scale.”
Visceral fat loss may inform diabetes prevention targets; hypothesis-generating and requires randomized confirmation.
RCT (n=366)
Does lifestyle-induced visceral fat loss improve long-term cardiometabolic health and reduce incident type 2 diabetes in participants of dietary trials?
Hazard Ratio: 0.72 (95% CI 0.54–0.94)
Lifestyle-induced visceral fat loss, rather than overall weight loss, is a key target for durable cardiometabolic health and reduces the long-term risk of incident type 2 diabetes.
Journal, society, and media accounts. Useful signal, not independent expert judgment.
This long-term follow-up of the CENTRAL and DIRECT-PLUS trials provides compelling evidence that visceral fat loss, independent of overall weight regain, has durable cardiometabolic benefits. The findings are highly relevant to preventive cardiology, shifting the focus from just weight loss to the importance of reducing visceral adiposity.
Klein et al. (2026) conducted an RCT in Cardiometabolic health (n=366). Lifestyle interventions (diet and physical activity) was evaluated on incident type 2 diabetes (HR 0.72, 95% CI 0.54-0.94). Each 10% intervention-induced loss of visceral adipose tissue was associated with a 28% lower risk of incident type 2 diabetes (HR 0.72; 95% CI 0.54-0.94) during 5- and 10-year follow-up.